Both in Pharmaceuticals
Arcutis Biotherapeutics vs Xenon Pharmaceuticals
Over the past year ARQT returned +29.2% and XENE returned −7.0%; their daily moves had a correlation of 0.33.
ARQT +29.2% XENE −7.0%Growth of $1, one year, split-adjusted
| Metric | ARQT | XENE |
|---|---|---|
| Price | $32.00 | $38.23 |
| Market cap | $4.02B | $3.70B |
| Today | +2.37% | +1.62% |
| 1 month | +27.2% | +1.8% |
| 6 months | +36.6% | −33.8% |
| Year to date | +10.2% | −14.7% |
| 1 year | +26.4% | −8.8% |
| Revenue growth (YoY) | +59.3% | — |
| Gross margin | 91.6% | — |
| Net margin | 11.6% | — |
| P/E (TTM) | 141.0× | — |
| Price / sales | 8.7× | — |
| Net cash | $129.7M | $930.7M |
| Dividend yield | — | — |
| Volatility (60d) | 53.5% | 82.4% |
| Short % of float | 18.0% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).